Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05107635 · ClinicalTrials.gov registry record
Inappropriate Sinus Tachycardia Registry
A clinical trial of Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia, sponsored by AtriCure.
- Recruiting
- Registry status
- 500
- Enrollment target
- 10
- Study locations
NCT05107635 is a study of Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia that is actively recruiting participants, run by AtriCure. The registered enrollment target is 500 participants, above the 56-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (793% higher). The trial reports 10 study locations across 8 states.
The verdict
NCT05107635, a study of Postural Tachycardia Syndrome and Inappropriate Sinus Tachycardia, is actively recruiting participants, sponsored by AtriCure.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
Conditions Studied
Interventions
- DEVICE AtriCure Commercially Available Devices
Study Locations (10)
California
- Stanford University - Palo Alto
- Sequoia Hospital - Redwood City
Florida
- University of Florida - Gainesville
- Sarasota Memorial Hospital - Sarasota
Kansas
- Kansas City Cardiac Arrhythmia Research - Kansas City
Maryland
- MedStar Health Research Institute - Hyattsville
Ohio
- The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital - Cincinnati
Texas
- Texas Cardiac Arrhythmia Research Foundation - Austin
Utah
- Intermountain Medical Center - Murray
Other
- Universitair Ziekenhuis Brussels - Brussels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2022-03-01 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05107635
The ClinicalTrials.gov registry entry for NCT05107635 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 56-participant average among 19 other Postural Tachycardia Syndrome trials with a reported enrollment target (793% higher). The listed sponsor is AtriCure, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Postural Tachycardia Syndrome appearing as the primary indexed condition, and to 1 intervention - of which AtriCure Commercially Available Devices is the first listed.
NCT05107635 reports 10 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Kansas.
Frequently Asked Questions
What is clinical trial NCT05107635 about?
NCT05107635 is a clinical study titled "Inappropriate Sinus Tachycardia Registry". The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, obs...
What is the current status of trial NCT05107635?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2022-03-01. Estimated completion is 2027-01.
What conditions does trial NCT05107635 study?
This clinical trial studies the following conditions: Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia.
What interventions are being tested in trial NCT05107635?
The interventions under investigation include: AtriCure Commercially Available Devices (DEVICE).
Who is sponsoring clinical trial NCT05107635?
This trial is sponsored by AtriCure, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05107635 being conducted?
This trial has 10 study locations across California, Florida, Kansas, Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postural Tachycardia Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Periaqueductal Gray-vagus Nerve Interface Malfunction Explain the Natural History With Its Numerous Co-morbidities?
RECRUITING · NA
-
Autoimmune Basis for Postural Tachycardia Syndrome
RECRUITING · NA
-
A Study of Pyridostigmine in Postural Tachycardia Syndrome
RECRUITING · Phase 2
-
Intravenous (IV) Saline and Exercise in Postural Tachycardia Syndrome (POTS)
ACTIVE NOT RECRUITING · NA
-
Acute Salt Handling in Orthostatic Intolerance
ACTIVE NOT RECRUITING · NA
-
POTS NET mRNA Functional Correlation With NET Activity
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Postural Tachycardia Syndrome
All registered trials for this condition
Inappropriate Sinus Tachycardia
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.